Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

SELL
$2.48 - $3.43 $496 - $686
-200 Reduced 0.59%
33,600 $90,000
Q3 2022

Oct 19, 2022

BUY
$3.14 - $6.43 $10,048 - $20,576
3,200 Added 10.46%
33,800 $110,000
Q1 2022

Apr 22, 2022

BUY
$6.47 - $9.57 $647 - $957
100 Added 0.33%
30,600 $230,000
Q4 2021

Jan 14, 2022

BUY
$9.02 - $13.5 $902 - $1,350
100 Added 0.33%
30,500 $282,000
Q3 2021

Oct 12, 2021

BUY
$13.71 - $17.18 $106,938 - $134,004
7,800 Added 34.51%
30,400 $433,000
Q2 2021

Jul 16, 2021

BUY
$14.92 - $23.23 $337,192 - $524,998
22,600 New
22,600 $376,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $408M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.